GLP-1 RA antiobesity medications: Patients’ No. 1 question

Medical Economics November 27, 2024
Richard Payerchin

Key Takeaways

• Patients are curious about GLP-1 RA antiobesity medications, necessitating discussions with healthcare providers.
• Dr. Robert Kushner, an expert in obesity and nutrition, stresses the importance of initiating these conversations.
• Informed dialogue between patients and providers is crucial for addressing concerns and understanding medication roles.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Patients have lots of questions...

Today's Sponsors

Today's Sponsor